Internal Medicine, Hematology & Oncology · San Juan, PR
NPI
1487938031
Since 2011
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
Hospital del Maestro, Suite 2002
San Juan, PR, 00918
Phone (787) 763-7365
Groups this clinician bills Medicare through
Medicare paid, 2024
$13K
240 services
Medicare patients, 2024
50
Average age 79
Drug cost, 2024
$3.0M
2,378 prescriptions
Company payments, 2025
$7,963
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Edgardo Luis Santiago-Guzman was code 99213 (office e&m - established), 72 times for 36 patients. In total Edgardo Luis Santiago-Guzman billed 240 services in 17 codes, and Medicare paid $13K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-08-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 72 | 36 | $45.83 | $3,300 |
By year: 2022 $98K for 5,994 services; 2023 $26K for 648 services; 2024 $13K for 240 services.
Medicare prescription drug claims, 2024
In 2024, the drug Edgardo Luis Santiago-Guzman prescribed most often to Medicare patients was Anastrozole, with 357 prescriptions and refills. In total Edgardo Luis Santiago-Guzman wrote 2,378 Medicare prescriptions that cost $3.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 357 | 489 | 72 | $6,781 |
| Dexamethasone Generic | 195 | 195 | 33 | $2,532 |
| Famotidine Generic | 182 | 208 | 48 | $1,543 |
| Prednisone Generic | 126 | 126 | 23 | $1,124 |
| Letrozole Generic | 95 | 133 | 20 | $1,583 |
| Ondansetron Hcl Generic | 91 | 91 | 34 | $907 |
| Hydroxyurea Generic | 88 | 108 | 16 | $2,188 |
| Gabapentin Generic | 55 | 61 | 15 | $482 |
| Pantoprazole Sodium Generic | 54 | 62 | 15 | $491 |
| Abiraterone Acetate Generic | 50 | 50 | Under 11 | $120K |
| Valacyclovir Valacyclovir Hcl | 46 | 46 | Under 11 | $590 |
| Ibandronate Sodium Generic | 38 | 53 | Under 11 | $866 |
| Eliquis Apixaban | 38 | 44 | Under 11 | $26K |
| Synthroid Levothyroxine Sodium | 32 | 48 | Under 11 | $2,298 |
| Xarelto Rivaroxaban | 31 | 39 | Under 11 | $22K |
Brand drugs: 373 claims; generic drugs: 2,005 claims; opioid claims: 24.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Edgardo Luis Santiago-Guzman $7,963 ($7,963 in general payments such as food, travel and fees) from 21 companies. The largest payer was E.R. Squibb & Sons, L.L.C. with $2,674.
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. BMY | 22 | $2,674 |
| Abbvie Inc. ABBV | 11 | $1,641 |
| Merck Sharp & Dohme LLC MRK | 17 | $1,503 |
| AstraZeneca Pharmaceuticals LP AZN | 19 | $520 |
| Novartis Pharmaceuticals Corporation NVS | 11 | $286 |
| Pbg Puerto Rico LLC | 11 | $243 |
| Bayer Puerto Rico Inc. BAYN.DE | 8 | $191 |
| Tempus AI, Inc TEM | 7 | $170 |
| Genentech USA, Inc. ROG.SW | 6 | $148 |
| Exelixis Inc. EXEL | 4 | $91.1 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.